These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18985539)

  • 1. Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease.
    Steenholdt C; Andresen L; Pedersen G; Hansen A; Brynskov J
    Scand J Gastroenterol; 2009; 44(2):195-204. PubMed ID: 18985539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
    Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
    Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
    Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
    Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients.
    Stanislawowski M; Wierzbicki PM; Golab A; Adrych K; Kartanowicz D; Wypych J; Godlewski J; Smoczynski M; Kmiec Z
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():71-5. PubMed ID: 20083854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease.
    Nishiwaki T; Ina K; Goto H; Watanabe O; Tsuzuki T; Furuta R; Ando T; Hibi K; Kusugami K
    J Gastroenterol; 2005 Feb; 40(2):128-36. PubMed ID: 15770395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of microbiota, Toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease.
    Kalliomäki M; Satokari R; Lähteenoja H; Vähämiko S; Grönlund J; Routi T; Salminen S
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):727-32. PubMed ID: 22134550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.
    Nielsen OH; Kirman I; Rüdiger N; Hendel J; Vainer B
    Scand J Gastroenterol; 2003 Feb; 38(2):180-5. PubMed ID: 12678335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.
    Renner M; Bergmann G; Krebs I; End C; Lyer S; Hilberg F; Helmke B; Gassler N; Autschbach F; Bikker F; Strobel-Freidekind O; Gronert-Sum S; Benner A; Blaich S; Wittig R; Hudler M; Ligtenberg AJ; Madsen J; Holmskov U; Annese V; Latiano A; Schirmacher P; Amerongen AV; D'Amato M; Kioschis P; Hafner M; Poustka A; Mollenhauer J
    Gastroenterology; 2007 Nov; 133(5):1499-509. PubMed ID: 17983803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease.
    Kruidenier L; Kuiper I; van Duijn W; Marklund SL; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):7-16. PubMed ID: 12950012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.
    Østvik AE; Granlund AV; Torp SH; Flatberg A; Beisvåg V; Waldum HL; Flo TH; Espevik T; Damås JK; Sandvik AK
    Clin Exp Immunol; 2013 Sep; 173(3):502-11. PubMed ID: 23668802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis.
    Singh JC; Cruickshank SM; Newton DJ; Wakenshaw L; Graham A; Lan J; Lodge JP; Felsburg PJ; Carding SR
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G514-24. PubMed ID: 15499080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression.
    Böcker U; Yezerskyy O; Feick P; Manigold T; Panja A; Kalina U; Herweck F; Rossol S; Singer MV
    Int J Colorectal Dis; 2003 Jan; 18(1):25-32. PubMed ID: 12458377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
    Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
    Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
    Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
    Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease.
    McKenzie SJ; Baker MS; Buffinton GD; Doe WF
    J Clin Invest; 1996 Jul; 98(1):136-41. PubMed ID: 8690784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.